Multiplex PCR tests have shown superior sensitivity and quicker time to result, compared to conventional methods for detection of infectious organisms present in patient samples.
Molecular test technology amplifies target DNA/RNA by over a billion times providing highly sensitive and reproducible results.
Seegene has made important contributions to the field of multiplex PCR testing with the development of DPO™, TOCE™, and MuDT™ technologies. Employed across our various products, these innovations make it possible to detect from among multiple pathogens in a single PCR channel, increasing the total number of candidate pathogens in a single PCR reaction, compared to standard practice.
Seegene’s technologies are uniquely valuable when identifying the causative pathogens of various infectious diseases, including genetic variants, and across a broad range of titers. Because only a single reaction is required to detect multiple targets of interest, testing is made quicker and more cost-effective by reducing the number of PCR reactions, reagents, hands-on time, and plates used.
Novaplex™ Assays are For Research Use Only. Not for Use in Diagnostic Procedures.